You are here

narcolepsy

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

Fierce Pharma

Flag link:

Scorpion Stings Harmony with Citizen’s Petition Threat for Sleepiness Drug

Scorpion Stings Harmony with Citizen’s Petition Threat for Sleepiness Drug

BioSpace

Harmony Biosciences

Scorpion Capital

citizen petitions

Flag link:

Jazz loses appeal, will have patent delisted from the Orange Book

Jazz loses appeal, will have patent delisted from the Orange Book

Endpoints

Flag link:

Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book

Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book

Endpoints

Flag link:

Competition is on the horizon for costly narcolepsy treatments

Competition is on the horizon for costly narcolepsy treatments

Pharmaphorum

Jazz Pharmaceuticals

Molina Healthcare

Harmony Biosciences

Flag link:

In Jazz case, FTC urges court to delist patent on blockbuster Xyrem

In Jazz case, FTC urges court to delist patent on blockbuster Xyrem

Fierce Pharma

Flag link:

Takeda cuts ties to cancer drug landed in $120M Turnstone deal

Takeda cuts ties to cancer drug landed in $120M Turnstone deal

Fierce Biotech

Turnstone Biologics

Flag link:

Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug

Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug

Fierce Pharma

Flag link:

Takeda halts trial of orexin drug in narcolepsy on safety grounds

Takeda halts trial of orexin drug in narcolepsy on safety grounds

Pharmaforum

clinical trials

Flag link:

Xywav Narcolepsy Drug Scores FDA Approval for Rare Sleep Disorder

Xywav Narcolepsy Drug Scores FDA Approval for Rare Sleep Disorder

Xtalks

Jazz Pharmaceuticals

Flag link:

Jazz Pharmaceuticals gets FDA OK for cataplexy drug as it prepares to replace old cash cow

Jazz Pharmaceuticals gets FDA OK for cataplexy drug as it prepares to replace old cash cow

Endpoints

Jazz Pharmaceuticals

Flag link:

Avadel's Once-Nightly Narcolepsy Drug Hits Three Co-Primary Endpoints in Late-Stage Trial

Avadel's Once-Nightly Narcolepsy Drug Hits Three Co-Primary Endpoints in Late-Stage Trial

BioSpace

clinical trials

Flag link:

Upcoming events – Avadel takes on Jazz and Axovant awaits early results

Upcoming events – Avadel takes on Jazz and Axovant awaits early results

EP Vantage

Jazz Pharmaceuticals

Parkinson's Disease

Flag link:

Jazz Pharma Files for FDA Approval of a New Narcolepsy Drug

Jazz Pharma Files for FDA Approval of a New Narcolepsy Drug

Motley Fool

Jazz Pharmaceuticals

Flag link:

An old, controversial Pfizer drug shows mid-stage efficacy against narcolepsy

An old, controversial Pfizer drug shows mid-stage efficacy against narcolepsy

Endpoints

Flag link:

Jazz Pharma Hits the Mark with Another Narcolepsy Treatment

Jazz Pharma Hits the Mark with Another Narcolepsy Treatment

BioSpace

Jazz Pharmaceuticals

Flag link:

Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed

Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed

Investors Business Daily

Wave Life Sciences

Jazz Pharmaceuticals

Flag link:

Harmony crosses finish line with Wakix for narcolepsy

Harmony crosses finish line with Wakix for narcolepsy

BioCentury

Harmony Biosciences

Flag link:

Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling

Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling

Fierce Pharma

Jazz Pharmaceuticals

Flag link:

Jazz's narcolepsy treatment passes Phase 3 test

Jazz's narcolepsy treatment passes Phase 3 test

Biopharma Dive

Jazz Pharmaceuticals

Flag link:

Pages